Colonoscopy surveillance after polypectomy and colorectal cancer resection: Consensus guidelines from the U.S. Multi-Society Task Force on Colorectal Cancer and the American Cancer Society

American Family Physician

Volumn 77, Issue 7, 2008, Pages

  Brooks, Durado D ^a   Winawer, Sidney J ^b   Rex, Douglas K ^c   Zauber, Ann G ^b   Kahi, Charles J ^c   Smith, Robert A ^a   Levin, Bernard ^d   Wender, Richard ^e  

^a AMERICAN CANCER SOCIETY   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SURGERY; COLON RESECTION; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; DYSPLASIA; ENDOSCOPIC SUBMUCOSAL DISSECTION; FOLLOW UP; HUMAN; POLYPECTOMY; PRACTICE GUIDELINE; RECTUM RESECTION; REVIEW; ADENOMATOUS POLYP; ARTICLE; COLON POLYP; COLORECTAL TUMOR; HEALTH SURVEY; NON PROFIT ORGANIZATION; UNITED STATES; UTILIZATION REVIEW;

ADENOMATOUS POLYPS; AMERICAN CANCER SOCIETY; COLONIC POLYPS; COLONOSCOPY; COLORECTAL NEOPLASMS; HUMANS; POPULATION SURVEILLANCE; UNITED STATES;

EID: 44449153485     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007;57(1):43-66.
2. Stryker SJ, Wolff BG, Culp CE, Libbe SD, Ilstrup DM, MacCarty RL. Natural history of untreated colonic polyps. Gastroenterology. 1987;93(5):1009-1013. (Pubitemid 18000643)
3. Vijan S, Inadomi J, Hayward RA, Hofer TP, Fendrick AM. Projections of demand and capacity for colonoscopy related to increasing rates of colorectal cancer screening in the United States. Aliment Pharmacol Ther. 2004;20(5):507-515. (Pubitemid 39243896)
4. Winawer S, Fletcher R, Rex D, et al., for the Gastrointestinal Consortium Panel. Colorectal cancer screening and surveillance: clinical guidelines and rationale - update based on new evidence. Gastroenterology. 2003;124(2):544-560.
5. Smith RA, von Eschenbach AC, Wender R, et al., for the ACS Prostate Cancer Advisory Committee, ACS Colorectal Cancer Advisory Committee, ACS Endometrial Cancer Advisory Committee. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001 - testing for early lung cancer detection [published correction appears in CA Cancer J Clin. 2001;51(3):150]. CA Cancer J Clin. 2001;51(1):38-75.
6. Mysliwiec PA, Brown ML, Klabunde CN, Ransohoff DF. Are physicians doing too much colonoscopy? A national survey of colorectal surveillance after polypectomy. Ann Intern Med. 2004;141(4):264-271. (Pubitemid 39079289)
7. Boolchand V, Olds G, Singh J, Singh P, Chak A, Cooper GS. Colorectal screening after polypectomy: a national survey study of primary care physicians. Ann Intern Med. 2006;145(9):654-659. (Pubitemid 46768840)
8. Nelson DB, McQuaid KR, Bond JH, Lieberman DA, Weiss DG, Johnston TK. Procedural success and complications of large-scale screening colonoscopy. Gastrointest Endosc. 2002;55(3):307-314. (Pubitemid 41115140)
9. Gatto NM, Frucht H, Sundararajan V, Jacobson JS, Grann VR, Neugut AI. Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study. J Natl Cancer Inst. 2003;95(3):230-236. (Pubitemid 36240636)
10. Levin TR, Zhao W, Conell C, et al. Complications of colonoscopy in an integrated health care delivery system. Ann Intern Med. 2006;145(12):880-886. (Pubitemid 351639963)
11. Winawer SJ, Zauber AG, Fletcher RH, et al., for the U.S. Multi-Society Task Force on Colorectal Cancer, American Cancer Society. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the U.S. Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin. 2006;56(3):143-159.
12. Rex DK, Kahi CJ, Levin B, et al., for the U.S. Multi-Society Task Force on Colorectal Cancer, American Cancer Society. Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and U.S. Multi-Society Task Force on Colorectal Cancer. CA Cancer J Clin. 2006;56(3):160-167.
13. Huang CS, O'Brien MJ, Yang S, Farraye FA. Hyperplastic polyps, serrated adenomas, and the serrated polyp neoplasia pathway. Am J Gastroenterol. 2004;99(11):2242-2255. (Pubitemid 39524717)
14. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993;329(27):1977-1981.
15. Citarda F, Tomaselli G, Capocaccia R, Barcherini S, Crespi M, for the Italian Multicentre Study Group. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut. 2001;48(6):812-815.
16. Atkin WS, Morson BC, Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med. 1992;326(10):658-662.
17. Winawer SJ, Zauber AG, O'Brien MJ, et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Engl J Med. 1993;328(13):901-906. (Pubitemid 23086641)
18. Haseman JH, Lemmel GT, Rahmani EY, Rex DK. Failure of colonoscopy to detect colorectal cancer: evaluation of 47 cases in 20 hospitals. Gastrointest Endosc. 1997;45(6):451-455. (Pubitemid 27424393)
19. Hixson LJ, Fennerty MB, Sampliner RE, Garewal HS. Prospective blinded trial of the colonoscopic miss-rate of large colorectal polyps. Gastrointest Endosc. 1991;37(2):125-127.
20. Rex DK, Cutler CS, Lemmel GT, et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology. 1997;112(1):24-28. (Pubitemid 27008981)
21. Barclay RI, Vicari JJ, Johanson JF, Greenlaw RI. Variation in adenoma detection rates and colonoscopic withdrawal times during screening colonoscopy [abstract]. Gastrointest Endosc. 2005;61(5):AB107.
22. Barclay RL, Vicari JJ, Doughty AS, Johanson JF, Greenlaw RL. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Engl J Med. 2006;355(24):2533-2541. (Pubitemid 44917501)
23. Rex DK, Bond JH, Winawer S, et al., for the U.S. Multi-Society Task Force on Colorectal Cancer. Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2002;97(6):1296-1308. (Pubitemid 34664769)
24. Robertson DJ, Greenberg ER, Beach M, et al. Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology. 2005;129(1):34-41. (Pubitemid 41002040)
25. Loeve F, van Ballegooijen M, Boer R, Kuipers EJ, Habbema JD. Colorectal cancer risk in adenoma patients: a nationwide study. Int J Cancer. 2004;111(1):147-151. (Pubitemid 38859296)
26. Bonithon-Kopp C, Piard F, Fenger C, et al., for the European Cancer Prevention Organisation Study Group. Colorectal adenoma characteristics as predictors of recurrence. Dis Colon Rectum. 2004;47(3):323-333.
27. Martinez ME, Sampliner R, Marshall JR, Bhattacharyya AK, Reid ME, Alberts DS. Adenoma characteristics as risk factors for recurrence of advanced adenomas. Gastroenterology. 2001;120(5):1077-1083. (Pubitemid 32246661)
28. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale [published corrections appear in Gastroenterology. 1997; 112(3):1060 and Gastroenterology. 1998;114(3):625]. Gastroenterology. 1997;112(2):594-642.
29. Burt RW. Colon cancer screening. Gastroenterology. 2000;119(3):837-853. (Pubitemid 30681143)
30. Barillari P, Ramacciato G, Manetti G, Bovino A, Sammartino P, Stipa V. Surveillance of colorectal cancer: effectiveness of early detection of intraluminal recurrences on prognosis and survival of patients treated for cure. Dis Colon Rectum. 1996;39(4):388-393. (Pubitemid 26116867)
31. Granqvist S, Karlsson T. Postoperative follow-up of patients with colorectal carcinoma by colonoscopy. Eur J Surg. 1992;158(5):307-312.
32. Castells A, Bessa X, Daniels M, et al. Value of postoperative surveillance after radical surgery for colorectal cancer: results of a cohort study. Dis Colon Rectum. 1998;41(6):714-723. (Pubitemid 28287543)
33. Obrand DI, Gordon PH. Incidence and patterns of recurrence following curative resection for colorectal carcinoma. Dis Colon Rectum. 1997;40(1):15-24. (Pubitemid 27056393)
34. Togashi K, Konishi F, Ozawa A, et al. Predictive factors for detecting colorectal carcinomas in surveillance colonoscopy after colorectal cancer surgery. Dis Colon Rectum. 2000;43(10 suppl):S47-S53. (Pubitemid 30783350)
35. Jeffery GM, Hickey BE, Hider P. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev. 2002;(1):CD002200.
36. Renehan AG, Egger M, Saunders MP, O'Dwyer ST. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ. 2002;324(7341):813. (Pubitemid 34280732)
37. Kronborg O, Hage E, Deichgraeber E. The remaining colon after radical surgery for colorectal cancer. The first three years of a prospective study. Dis Colon Rectum. 1983;26(3):172-176. (Pubitemid 13158552)
38. Holm T, Johansson H, Cedermark B, Ekelund G, Rutqvist LE. Influence of hospital- and surgeon-related factors on outcome after treatment of rectal cancer with or without preoperative radiotherapy. Br J Surg. 1997;84(5):657-663. (Pubitemid 27208288)
39. Porter GA, Soskolne CL, Yakimets WW, Newman SC. Surgeon-related factors and outcome in rectal cancer. Ann Surg. 1998;227(2):157-167. (Pubitemid 28087906)
40. McArdle CS, Hole D. Impact of variability among surgeons on postoperative morbidity and mortality and ultimate survival. BMJ. 1991;302(6791):1501-1505.
41. Steele RJ. The influence of surgeon case volume on outcome in site-specific cancer surgery. Eur J Surg Oncol. 1996;22(3):211-213. (Pubitemid 126689800)
42. Langevin JM, Nivatvongs S. The true incidence of synchronous cancer of the large bowel. A prospective study. Am J Surg. 1984;147(3):330-333. (Pubitemid 14154580)
43. Pagana TJ, Ledesma EJ, Mittelman A, Nava HR. The use of colonoscopy in the study of synchronous colorectal neoplasms. Cancer. 1984;53(2):356-359. (Pubitemid 14180756)
44. Carlsson G, Petrelli NJ, Nava H, Herrera L, Mittelman A. The value of colonoscopic surveillance after curative resection for colorectal cancer or synchronous adenomatous polyps. Arch Surg. 1987;122(11):1261-1263. (Pubitemid 18021279)
45. Weber CA, Deveney KE, Pellegrini CA, Way LW. Routine colonoscopy in the management of colorectal carcinoma. Am J Surg. 1986;152(1):87-92. (Pubitemid 16069559)
46. Green RJ, Metlay JP, Propert K, et al. Surveillance for second primary colorectal cancer after adjuvant chemotherapy: an analysis of Intergroup 0089. Ann Intern Med. 2002;136(4):261-269. (Pubitemid 34150755)
47. Juhl G, Larson GM, Mullins R, Bond S, Polk HC Jr. Six-year results of annual colonoscopy after resection of colorectal cancer. World J Surg. 1990;14(2):255-260. (Pubitemid 20200816)
48. Zauber AG, Winawer SJ, Bond JH, et al. FOBT is of limited value in post-polypectomy colonoscopy surveillance [abstract]. Gastroenterology. 2002;122(4 suppl 1):A486. Abstract T1589.
49. Bampton PA, Sandford JJ, Cole SR, et al. Interval faecal occult blood testing in a colonoscopy based screening programme detects additional pathology. Gut. 2005;54(6):803-806. (Pubitemid 40732097)
50. Finkelstein S, Bini EJ. Annual fecal occult blood testing can be safely suspended for up to 5 years after a negative colonoscopy in asymptomatic average-risk patients [abstract]. Gastrointest Endosc. 2005;61(5):AB250.